Form EFFECT INNOCAN PHARMA Corp
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 5:00 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Landmark Medicines Advances Proprietary Nasal GLP-1 Platform Towards Human Evaluation
- Institute for Protein Innovation Appoints Kevin J. Harvey, Ph.D., as President and Chief Executive Officer
- New Oriental to Report First Quarter 2027 Financial Results on October 28, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
